undefined

Sydney Lupkin

NPR's pharmaceuticals correspondent, known for her reporting on drug pricing and healthcare.

Top 5 podcasts with Sydney Lupkin

Ranked by the Snipd community
undefined
Aug 30, 2023 • 12min

After 30 Years, Here's Biden's Plan To Lower Drug Costs: Negotiate

Sydney Lupkin, NPR's pharmaceuticals correspondent, breaks down a pivotal moment in U.S. healthcare policy. The government can now negotiate Medicare drug prices, a move decades in the making. She discusses the ten drugs under negotiation and what that means for seniors facing high costs. The challenges ahead include pharmaceutical lobbying and potential legal battles. Furthermore, Lupkin analyzes how this initiative could sway upcoming elections and reshape public opinion on healthcare affordability. It's an enlightening conversation on a crucial topic.
undefined
Jul 22, 2022 • 13min

The Accelerated Approvals Process: Are Drugmakers Fulfilling Their Promises?

Sydney Lupkin, NPR's pharmaceuticals correspondent, dives into the world of accelerated drug approvals and the promises drugmakers must keep. She discusses the urgent history behind this FDA process, particularly during the AIDS crisis. Lupkin reveals concerning stories, including tragic outcomes linked to insufficiently validated drugs. The conversation sheds light on the challenges of ensuring ongoing accountability and the dire need for thorough follow-up studies to protect patient safety and trust in the pharmaceutical system.
undefined
Sep 8, 2021 • 13min

Fewer COVID Vaccine Doses Materialized Last Fall Than The U.S. Government Hoped

Sydney Lupkin, NPR's pharmaceuticals correspondent, dives into the complexities of Operation Warp Speed's vaccine rollout. She reveals how Pfizer initially delivered fewer COVID vaccine doses than expected, leaving federal officials perplexed. Lupkin discusses the unpredictable hurdles in mass production and highlights the impact of supply chain issues. The conversation also touches on the critical importance of transparency and communication between the government and pharmaceutical companies, emphasizing lessons learned for future public health responses.
undefined
May 6, 2021 • 15min

Patents Are Just One Piece Of The Global Vaccine Manufacturing Problem

Sydney Lupkin, NPR's pharmaceutical correspondent, dives into the complexities of global vaccine manufacturing amidst President Biden's push for patent waivers. She discusses the critical role of supply chains and technical expertise in producing vaccines, especially for countries like India and South Africa. The conversation also tackles vaccine hesitancy, emphasizing the importance of trust in healthcare through personal stories of individuals who overcame their doubts. Additionally, urban vs. rural vaccination disparities highlight unique community challenges in the U.S.
undefined
Mar 2, 2020 • 12min

A Tale Of Two (Very Different) Drug Prices

Sydney Lupkin, NPR's pharmaceuticals correspondent, sheds light on a family's struggle with staggering drug prices. She dives into a story where a dad discovers an identical medication for his daughter costing thousands less. The discussion highlights the complex web of healthcare costs, insurance challenges, and the emotional toll on families. Lupkin offers savvy tips for navigating the high costs of prescription medications, emphasizing the importance of understanding drug pricing disparities and advocating for accessible healthcare.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app